MNOV MediciNova, Inc.

NSD
$2.58

MediciNova, Inc. (MNOV) is expected to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is a loss of $0.06 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +95.5% since its last earnings release on August 13, 2026.

MediciNova Beat Consensus Estimates
Thursday, August 13, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · After Close
Earnings Whisper
-
vs ($0.06)
Rev est $150K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.07

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About MediciNova, Inc.

MediciNova Inc is a development stage biopharmaceutical company. It is engaged in acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.